Trial Profile
A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting
Status:
Suspended
Phase of Trial:
Phase III
Latest Information Update: 30 Apr 2018
Price :
$35
*
At a glance
- Drugs Lebrikizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Roche
- 01 Oct 2015 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
- 16 Sep 2015 New trial record